➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
McKinsey
Moodys
Harvard Business School
Express Scripts

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021288


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 021288 describes TRELSTAR, which is a drug marketed by Allergan and is included in three NDAs. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the TRELSTAR profile page.

The generic ingredient in TRELSTAR is triptorelin pamoate. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the triptorelin pamoate profile page.
Summary for 021288
Tradename:TRELSTAR
Applicant:Allergan
Ingredient:triptorelin pamoate
Patents:0
Medical Subject Heading (MeSH) Categories for 021288
Suppliers and Packaging for NDA: 021288
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 021288 NDA Allergan, Inc. 0023-5904 0023-5904-12 1 KIT in 1 CARTON (0023-5904-12) * 2 mL in 1 VIAL, SINGLE-DOSE * 2 mL in 1 SYRINGE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAMUSCULARStrengthEQ 11.25MG BASE/VIAL
Approval Date:Jun 29, 2001TE:RLD:Yes

Expired US Patents for NDA 021288

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 021288-001 Jun 29, 2001   Start Trial   Start Trial
Allergan TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 021288-001 Jun 29, 2001   Start Trial   Start Trial
Allergan TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 021288-001 Jun 29, 2001   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
McKesson
Merck
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.